Pharmacy reimbursement law goes into effect Wednesday - Alabama Daily News
Alabama's new pharmacy reimbursement law takes effect Wednesday, requiring pharmacies to accept reimbursement rates set by pharmacy benefit managers (PBMs) or risk being excluded from networks. This impacts independent and chain pharmacies, particularly those dispensing controlled substances.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 16, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies in Alabama should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately (law effective Wednesday). Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Pharmacies must accept PBM-set reimbursement rates as of Wednesday; failure to do so may result in network termination.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies in Alabama
What you must do
Review current PBM contracts and reimbursement rates; ensure compliance with new law by Wednesday.
Deadline
Immediately (law effective Wednesday)
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- IL HB0004: MEDICAID-PHARMACY SERVICES
- Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661
- Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
- Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability
- Amanda Ward, N.D.; Decision and Order